LEE STEVEN HYOSIG 4

What Happened
Lee Steven Hyosig, SVP, Controller & CAO of Bausch Health Companies Inc., received an award of 45,868 restricted share units (RSUs) on February 25, 2026. The Form 4 reports the grant at $0.00 per share (total reported value $0); no cash purchase or sale occurred. Per the filing, the RSUs vest one‑third on each of the first three anniversaries after the grant and, upon vesting, will be settled in Bausch Health common shares.

Key Details

• Transaction date: 2026-02-25 (Transaction code: A = Award/Grant)
• Shares/units granted: 45,868 RSUs; Reported price: $0.00; Reported total: $0
• Vesting/settlement: Vests one‑third each year for three years; vested RSUs settled in common shares (see footnote F1)
• Shares owned after transaction: Not specified in the filing
• Filing date: 2026-02-27 — filed within the typical two-business-day Form 4 window (timely)
• No 10b5-1 plan, tax withholding, or cashless exercise noted in the filing

Context
RSU grants are a form of compensation rather than an open‑market purchase or sale. They create a future entitlement to shares if the insider remains in service and the RSUs vest; they do not by themselves indicate immediate buying or selling intent. Retail investors typically view these as routine executive compensation unless accompanied by large purchases or sales.